+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Atracurium Market by Application, End User, Distribution Channel, Form, Route Of Administration - Global Forecast to 2030- Product Image
Atracurium Market by Application, End User, Distribution Channel, Form, Route Of Administration - Global Forecast to 2030- Product Image
Sale

Atracurium Market by Application, End User, Distribution Channel, Form, Route Of Administration - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6013935
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Atracurium Market grew from USD 242.31 million in 2024 to USD 251.75 million in 2025. It is expected to continue growing at a CAGR of 3.78%, reaching USD 302.90 million by 2030.

Atracurium Unveiled A Foundation for Strategic Insights

Atracurium has emerged as a cornerstone neuromuscular blocking agent in modern anesthesia and critical care, owing to its predictable pharmacokinetics and organ-independent elimination. This executive summary synthesizes current developments driving adoption, pinpointing regulatory, clinical, and commercial factors reshaping demand across intensive care units and surgical settings. By distilling key drivers, restraints, and emerging dynamics, we offer a clear, concise launch point for stakeholders navigating the complexities of the global atracurium market.

The path forward for atracurium hinges on integrating innovative delivery formats, optimizing formulated protocols for bolus injection and continuous infusion, and responding to evolving clinician preferences in diagnostic procedures, mechanical ventilation, and a broad spectrum of surgical specialties. This overview underscores the intersection of clinical efficacy, patient safety, and economic considerations in intensive care and operating theaters alike, setting a foundation for data-driven decisions and strategic planning.

Innovations and Digital Integration Reshaping Atracurium Use

The atracurium landscape is undergoing transformative shifts fueled by breakthroughs in molecular design, competitive product launches, and progressive regulatory approvals. Recent momentum stems from novel formulations such as pre-filled syringes designed for precise single-dose administration and lyophilized powders optimized for multi-dose and single-dose vial configurations. These advancements address clinician demands for streamlined preparation workflows and enhanced dosing accuracy.

Concurrently, digital integration of dosing calculators within anesthesia management platforms and the expansion of tele-intensive care services are redefining how neuromuscular blockers are administered and monitored. Pioneering collaborations between contract manufacturers and innovation labs are accelerating life-cycle developments, while new generics entering the market intensify price competition and broaden accessibility. Together, these innovations are steering the atracurium segment toward more efficient protocols and diversified delivery systems.

Tariff-Driven Cost Pressures Redefining Supply Strategies

United States tariffs implemented in early 2025 have reverberated through global supply chains, influencing pricing structures and procurement strategies for neuromuscular blockade agents. By imposing additional duties on select raw materials and active pharmaceutical ingredients, tariff measures have elevated production costs for contract manufacturers and originator companies alike. This cost increase has been partially absorbed through optimized manufacturing runs and refined purification techniques, yet end-market prices reflect a noticeable uptick, particularly in hospital pharmacies sourcing in-house and outsourced inventory.

Hospital administrators and procurement teams are reevaluating their distribution channel strategies, weighing the relative cost benefits of online prescription pharmacies versus traditional retail chains. In parallel, some institutions are establishing regional buffer stocks to mitigate supply disruptions, while ambulatory surgery centers are negotiating long-term agreements to stabilize pricing. The net effect of these shifts underscores the critical need for adaptive sourcing models and agile financial planning in maintaining uninterrupted access to atracurium therapies.

Segment Performance Illuminates Growth Avenues

A granular examination of market segmentation reveals differentiated growth trajectories across clinical applications, end users, distribution pathways, delivery formats, and administration routes. Within application realms, the intensive care segment encompassing diagnostic procedures and mechanical ventilation exhibits robust utilization rates, while surgical procedures in cardiovascular, general, neurological, and orthopedic disciplines continue to expand as minimally invasive techniques proliferate.

End users such as ambulatory surgery centers-both hospital affiliated and standalone-are capitalizing on streamlined anesthesia protocols, while specialty clinics and private hospitals demonstrate higher adoption rates driven by procedural volumes and reimbursement frameworks. Distribution spans in-house and outsourced hospital pharmacies alongside online prescription and OTC platforms, each calibrated to balance cost efficiency with supply security. In terms of form, lyophilized powder offerings in multi-dose and single-dose vials coexist with the growing popularity of single-dose pre-filled syringes. Intravenous administration remains paramount, with bolus injection protocols thriving in rapid induction scenarios and continuous infusion favored for extended neuromuscular blockade in critical care.

Regional Dynamics Chart Distinct Adoption Paths

Regional dynamics play a pivotal role in shaping the atracurium marketplace, with the Americas leading adoption through well-established ICU infrastructures and high procedural volumes in cardiovascular and orthopedic surgeries. In North America, strategic alliances between supplier networks and major hospital chains have bolstered distribution resilience. Mexico and Brazil are emerging as high-potential markets due to population growth and healthcare modernization efforts.

Across Europe, the Middle East & Africa, stringent regulatory environments and centralized procurement in nations such as Germany and the United Kingdom influence product standards and pricing benchmarks. Gulf Cooperation Council countries are investing in advanced anesthesia facilities, fostering uptake of premium delivery formats. In Asia-Pacific, expanding private healthcare investments and a surge in elective surgeries drive demand. China’s domestic production capacity and India’s role as a pharmaceuticals hub both accelerate availability and competitive pricing, positioning the region as a critical battleground for market share.

Competitive Strategies Steering Market Leadership

Key industry players are deploying varied strategies to secure leadership in the atracurium market. Established multinational pharmaceutical companies leverage integrated R&D pipelines, expansive manufacturing networks, and deep clinical trial expertise to sustain premium formulations and extend life-cycle portfolios. Meanwhile, specialty injectables manufacturers focus on operational excellence in sterile production and nimble scale-up capabilities to capture niche segments.

Generic entrants, backed by formidable synthesis capabilities and competitive pricing models, are intensifying market pressure, particularly in cost-sensitive channels such as retail pharmacies and public hospitals. Strategic partnerships between biotech innovators and contract development organizations are accelerating access to advanced pre-filled syringe platforms. Collectively, these competitive dynamics underscore a landscape characterized by continuous innovation, margin optimization initiatives, and alliances that bridge global reach with local responsiveness.

Strategic Imperatives for Maximizing Competitive Edge

Industry leaders must act decisively to capitalize on evolving market conditions. First, investing in flexible manufacturing lines capable of switching between lyophilized powder and pre-filled syringe formats will enhance response to fluctuating demand patterns. Second, forging strategic partnerships with regional distribution networks in growth hotspots can secure preferential procurement contracts and reinforce supply chains against tariff volatility.

Third, embracing digital anesthesia management tools and tele-ICU platforms will not only improve dosage accuracy but also support value-based care models. Fourth, developing educational programs for clinical end users-spanning ambulatory surgery centers, specialty clinics, and public hospitals-can drive adoption of best practices in bolus injection and continuous infusion protocols. Finally, establishing a robust regulatory intelligence function to track policy shifts across the Americas, Europe Middle East & Africa, and Asia-Pacific regions will position organizations to preempt compliance risks and unlock market expansion.

Rigorous Methodology Underpinning Actionable Insights

This analysis is grounded in a multi-faceted research methodology combining primary interviews, secondary data aggregation, and rigorous validation processes. Stakeholder consultations with anesthesiologists, ICU directors, procurement managers, and distribution executives provided firsthand perspectives on usage trends, dosing preferences, and supply chain challenges. Comprehensive reviews of regulatory filings, clinical trial registries, and patent landscapes furnished insights into formulation approvals and patent expirations.

Secondary sources-including industry journals, government publications, and financial reports-were systematically analyzed to corroborate primary findings and ensure data integrity. A proprietary scoring framework evaluated companies on R&D output, manufacturing capacity, and distribution reach. Market segmentation and regional breakdowns were validated through triangulation of shipment volumes, sales revenues, and pricing indices. Throughout the research process, methodological rigor and transparency guided our approach, delivering a robust and defensible market intelligence output.

Converging Drivers Set the Stage for Next-Gen Growth

In conclusion, the atracurium market stands at a critical inflection point where innovation, regulatory dynamics, and economic pressures converge to reshape supply and utilization patterns. Stakeholders who proactively adapt to tariff adjustments, optimize segmentation strategies across intensive care and surgical applications, and harness emerging distribution channels will secure sustainable growth.

Regional diversification, manufacturing agility, and strategic partnerships will define market leaders in the years ahead. By leveraging detailed segmentation insights-from ambulatory surgery centers to online pharmacies and advanced pre-filled syringe platforms-organizations can tailor their approaches to meet specific end-user needs. Ultimately, the capacity to translate these insights into precise execution plans will determine long-term competitive advantage and drive value for both patients and providers.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Intensive Care
      • Diagnostic Procedures
      • Mechanical Ventilation
    • Surgical Procedures
      • Cardiovascular Surgery
      • General Surgery
      • Neurological Surgery
      • Orthopedic Surgery
  • End User
    • Ambulatory Surgery Centers
      • Hospital Affiliated Centers
      • Standalone Centers
    • Clinics
      • General Clinics
      • Specialty Clinics
    • Hospitals
      • Private Hospitals
      • Public Hospitals
  • Distribution Channel
    • Hospital Pharmacies
      • In-House Pharmacy
      • Outsourced Pharmacy
    • Online Pharmacies
      • Otc Pharmacies
      • Prescription Pharmacies
    • Retail Pharmacies
      • Chain Pharmacies
      • Independent Pharmacies
  • Form
    • Lyophilized Powder
      • Multi Dose Vial
      • Single Dose Vial
    • Pre-Filled Syringe
      • Single Dose Syringe
  • Route Of Administration
    • Intravenous
      • Bolus Injection
      • Continuous Infusion
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Pfizer Inc.
  • Fresenius Kabi AG
  • Baxter International Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Hikma Pharmaceuticals PLC
  • Sagent Pharmaceuticals, Inc.
  • Cipla Limited
  • Sun Pharmaceutical Industries Ltd.
  • Acella Pharmaceuticals, LLC

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Atracurium Market, by Application
8.1. Introduction
8.2. Intensive Care
8.2.1. Diagnostic Procedures
8.2.2. Mechanical Ventilation
8.3. Surgical Procedures
8.3.1. Cardiovascular Surgery
8.3.2. General Surgery
8.3.3. Neurological Surgery
8.3.4. Orthopedic Surgery
9. Atracurium Market, by End User
9.1. Introduction
9.2. Ambulatory Surgery Centers
9.2.1. Hospital Affiliated Centers
9.2.2. Standalone Centers
9.3. Clinics
9.3.1. General Clinics
9.3.2. Specialty Clinics
9.4. Hospitals
9.4.1. Private Hospitals
9.4.2. Public Hospitals
10. Atracurium Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.2.1. In-House Pharmacy
10.2.2. Outsourced Pharmacy
10.3. Online Pharmacies
10.3.1. Otc Pharmacies
10.3.2. Prescription Pharmacies
10.4. Retail Pharmacies
10.4.1. Chain Pharmacies
10.4.2. Independent Pharmacies
11. Atracurium Market, by Form
11.1. Introduction
11.2. Lyophilized Powder
11.2.1. Multi Dose Vial
11.2.2. Single Dose Vial
11.3. Pre-Filled Syringe
11.3.1. Single Dose Syringe
12. Atracurium Market, by Route Of Administration
12.1. Introduction
12.2. Intravenous
12.2.1. Bolus Injection
12.2.2. Continuous Infusion
13. Americas Atracurium Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Atracurium Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Atracurium Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Pfizer Inc.
16.3.2. Fresenius Kabi AG
16.3.3. Baxter International Inc.
16.3.4. Teva Pharmaceutical Industries Ltd.
16.3.5. Viatris Inc.
16.3.6. Hikma Pharmaceuticals PLC
16.3.7. Sagent Pharmaceuticals, Inc.
16.3.8. Cipla Limited
16.3.9. Sun Pharmaceutical Industries Ltd.
16.3.10. Acella Pharmaceuticals, LLC
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ATRACURIUM MARKET MULTI-CURRENCY
FIGURE 2. ATRACURIUM MARKET MULTI-LANGUAGE
FIGURE 3. ATRACURIUM MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ATRACURIUM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ATRACURIUM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ATRACURIUM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ATRACURIUM MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ATRACURIUM MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ATRACURIUM MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ATRACURIUM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ATRACURIUM MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ATRACURIUM MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ATRACURIUM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ATRACURIUM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ATRACURIUM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ATRACURIUM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ATRACURIUM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ATRACURIUM MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ATRACURIUM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ATRACURIUM MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ATRACURIUM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ATRACURIUM MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ATRACURIUM MARKET SIZE, BY MECHANICAL VENTILATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ATRACURIUM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ATRACURIUM MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ATRACURIUM MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ATRACURIUM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ATRACURIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ATRACURIUM MARKET SIZE, BY STANDALONE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ATRACURIUM MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ATRACURIUM MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ATRACURIUM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ATRACURIUM MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ATRACURIUM MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ATRACURIUM MARKET SIZE, BY IN-HOUSE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ATRACURIUM MARKET SIZE, BY OUTSOURCED PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ATRACURIUM MARKET SIZE, BY OTC PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ATRACURIUM MARKET SIZE, BY PRESCRIPTION PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ATRACURIUM MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ATRACURIUM MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ATRACURIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ATRACURIUM MARKET SIZE, BY MULTI DOSE VIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ATRACURIUM MARKET SIZE, BY SINGLE DOSE VIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL ATRACURIUM MARKET SIZE, BY SINGLE DOSE SYRINGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL ATRACURIUM MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL ATRACURIUM MARKET SIZE, BY BOLUS INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL ATRACURIUM MARKET SIZE, BY CONTINUOUS INFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS ATRACURIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS ATRACURIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES ATRACURIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES ATRACURIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES ATRACURIUM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 90. CANADA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. CANADA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2030 (USD MILLION)
TABLE 92. CANADA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 93. CANADA ATRACURIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. CANADA ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 95. CANADA ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 96. CANADA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 97. CANADA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. CANADA ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 99. CANADA ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 100. CANADA ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 101. CANADA ATRACURIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 102. CANADA ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2030 (USD MILLION)
TABLE 103. CANADA ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2030 (USD MILLION)
TABLE 104. CANADA ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 105. CANADA ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 106. MEXICO ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. MEXICO ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2030 (USD MILLION)
TABLE 108. MEXICO ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 109. MEXICO ATRACURIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. MEXICO ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 111. MEXICO ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 112. MEXICO ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 113. MEXICO ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. MEXICO ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 115. MEXICO ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 116. MEXICO ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 117. MEXICO ATRACURIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 118. MEXICO ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2030 (USD MILLION)
TABLE 119. MEXICO ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2030 (USD MILLION)
TABLE 120. MEXICO ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. MEXICO ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL ATRACURIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL ATRACURIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA ATRACURIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA ATRACURIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 187. GERMANY ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. GERMANY ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2030 (USD MILLION)
TABLE 189. GERMANY ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 190. GERMANY ATRACURIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. GERMANY ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 192. GERMANY ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 193. GERMANY ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 194. GERMANY ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. GERMANY ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 196. GERMANY ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 197. GERMANY ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 198. GERMANY ATRACURIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 199. GERMANY ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2030 (USD MILLION)
TABLE 200. GERMANY ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2030 (USD MILLION)
TABLE 201. GERMANY ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 202. GERMANY ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 203. FRANCE ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. FRANCE ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2030 (USD MILLION)
TABLE 205. FRANCE ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 206. FRANCE ATRACURIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. FRANCE ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 208. FRANCE ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 209. FRANCE ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 210. FRANCE ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. FRANCE ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 212. FRANCE ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 213. FRANCE ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 214. FRANCE ATRACURIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 215. FRANCE ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2030 (USD MILLION)
TABLE 216. FRANCE ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2030 (USD MILLION)
TABLE 217. FRANCE ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 218. FRANCE ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. RUSSIA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2030 (USD MILLION)
TABLE 221. RUSSIA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA ATRACURIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA ATRACURIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 235. ITALY ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. ITALY ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2030 (USD MILLION)
TABLE 237. ITALY ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 238. ITALY ATRACURIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. ITALY ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 240. ITALY ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 241. ITALY ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 242. ITALY ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. ITALY ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 244. ITALY ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 245. ITALY ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 246. ITALY ATRACURIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 247. ITALY ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2030 (USD MILLION)
TABLE 248. ITALY ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2030 (USD MILLION)
TABLE 249. ITALY ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 250. ITALY ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 251. SPAIN ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. SPAIN ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2030 (USD MILLION)
TABLE 253. SPAIN ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 254. SPAIN ATRACURIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. SPAIN ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 256. SPAIN ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 257. SPAIN ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 258. SPAIN ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 259. SPAIN ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 260. SPAIN ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 261. SPAIN ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 262. SPAIN ATRACURIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 263. SPAIN ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2030 (USD MILLION)
TABLE 264. SPAIN ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2030 (USD MILLION)
TABLE 265. SPAIN ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 266. SPAIN ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES ATRACURIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES ATRACURIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. SAUDI ARABIA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 286. SAUDI ARABIA ATRACURIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 288. SAUDI ARABIA ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 290. SAUDI ARABIA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 292. SAUDI ARABIA ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 294. SAUDI ARABIA ATRACURIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2030 (USD MILLION)
TABLE 296. SAUDI ARABIA ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 298. SAUDI ARABIA ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 299. SOUTH AFRICA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. SOUTH AFRICA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2030 (USD MILLION)
TABLE 301. SOUTH AFRICA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 302. SOUTH AFRICA ATRACURIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. SOUTH AFRICA ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 304. SOUTH AFRICA ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 305. SOUTH AFRICA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 306. SOUTH AFRICA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. SOUTH AFRICA ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 308. SOUTH AFRICA ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 310. SOUTH AFRICA ATRACURIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2030 (USD MILLION)
TABLE 312. SOUTH AFRICA ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 314. SOUTH AFRICA ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 315. DENMARK ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 316. DENMARK ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2030 (USD MILLION)
TABLE 317. DENMARK ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 318. DENMARK ATRACURIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. DENMARK ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 320. DENMARK ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 321. DENMARK ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 322. DENMARK ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 323. DENMARK ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 324. DENMARK ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 325. DENMARK ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 326. DENMARK ATRACURIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 327. DENMARK ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2030 (USD MILLION)
TABLE 328. DENMARK ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2030 (USD MILLION)
TABLE 329. DENMARK ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 330. DENMARK ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 331. NETHERLANDS ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 332. NETHERLANDS ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2030 (USD MILLION)
TABLE 333. NETHERLANDS ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 334. NETHERLANDS ATRACURIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 335. NETHERLANDS ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 336. NETHERLANDS ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 337. NETHERLANDS ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 338. NETHERLANDS ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 339. NETHERLANDS ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 340. NETHERLANDS ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 341. NETHERLANDS ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 342. NETHERLANDS ATRACURIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 343. NETHERLANDS ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2030 (USD MILLION)
TABLE 344. NETHERLANDS ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2030 (USD MILLION)
TABLE 345. NETHERLANDS ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 346. NETHERLANDS ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 347. QATAR ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 348. QATAR ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2030 (USD MILLION)
TABLE 349. QATAR ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 350. QATAR ATRACURIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 351. QATAR ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 352. QATAR ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 353. QATAR ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 354. QATAR ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 355. QATAR ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 356. QATAR ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 357. QATAR ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 358. QATAR ATRACURIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 359. QATAR ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2030 (USD MILLION)
TABLE 360. QATAR ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2030 (USD MILLION)
TABLE 361. QATAR ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 362. QATAR ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 363. FINLAND ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 364. FINLAND ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2030 (USD MILLION)
TABLE 365. FINLAND ATRACURIUM MA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Atracurium market report include:
  • Pfizer Inc.
  • Fresenius Kabi AG
  • Baxter International Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Hikma Pharmaceuticals PLC
  • Sagent Pharmaceuticals, Inc.
  • Cipla Limited
  • Sun Pharmaceutical Industries Ltd.
  • Acella Pharmaceuticals, LLC

Table Information

Report AttributeDetails
No. of Pages180
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 251.75 Million
Forecasted Market Value ( USD ) by 2030 $ 302.9 Million
Compound Annual Growth Rate3.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Atracurium Besylate (CAS 64228-81-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Atracurium Besylate (CAS 64228-81-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Local Anesthesia Drugs Market by Route Administration, Drug Class, Product Type, Formulation, End-User, Distribution Channel, Application - Global Forecast to 2030 - Product Image

Local Anesthesia Drugs Market by Route Administration, Drug Class, Product Type, Formulation, End-User, Distribution Channel, Application - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Bupivacaine Liposome Injection Market by End Use, Indication, Application, Distribution Channel, Patient Type, Product Type, Packaging - Global Forecast to 2030 - Product Image

Bupivacaine Liposome Injection Market by End Use, Indication, Application, Distribution Channel, Patient Type, Product Type, Packaging - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
General Anesthesia Drugs Market Size, Share & Trends Analysis Report By Drug (Propofol), By Route Of Administration (Intravenous), By End-use (Hospitals), By Application, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

General Anesthesia Drugs Market Size, Share & Trends Analysis Report By Drug (Propofol), By Route Of Administration (Intravenous), By End-use (Hospitals), By Application, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Europe Anesthesia Needles and Syringes Market Size, Share and Trends Analysis Report by Product (Anesthesia Needles, Anesthesia Syringes), Safety Features (NRFit, Traditional), End-use, and Country 2024-2030 - Product Image

Europe Anesthesia Needles and Syringes Market Size, Share and Trends Analysis Report by Product (Anesthesia Needles, Anesthesia Syringes), Safety Features (NRFit, Traditional), End-use, and Country 2024-2030

  • Report
  • 100 Pages
  • Europe
From

About the Market

Atracurium is a neuromuscular blocking drug used in anesthetic drugs. It is a synthetic, short-acting, non-depolarizing muscle relaxant that is used to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. It is also used to reduce the amount of anesthetic drugs needed during surgery. Atracurium is metabolized by the enzyme pseudocholinesterase, which is found in the plasma and liver. Atracurium is available in a variety of formulations, including injection, infusion, and inhalation. It is typically administered intravenously, but can also be administered intramuscularly or subcutaneously. The drug is available in both generic and branded forms. The Atracurium market is highly competitive, with several major players in the market. Some of the major companies in the market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Teva Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.